Medtronic expanded its Touch Surgery Ecosystem (TSE) in April 2024 by launching the Live Stream function in the training app.

Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.

Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain ...

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology ...

The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

HeartBeam has announced a partnership with AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility.

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...